Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer - PubMed (original) (raw)

. 2000 Jul 1;60(13):3359-63.

Affiliations

• PMID: 10910038

Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancer

D A Kirschmann et al. Cancer Res. 2000.

Abstract

We previously identified a down-regulation in heterochromatin-associated protein 1 (HP1)Hsalpha expression in MDA-MB-231 breast carcinoma cells (highly invasive/metastatic) compared with MCF-7 cells (poorly invasive/nonmetastatic). In this study, we demonstrate that HP1Hsalpha, but not HP1Hsbeta or HP1Hsgamma, is down-regulated at the mRNA and protein levels in highly invasive/metastatic breast cancer cell lines. In agreement, little to no nuclear HP1Hsalpha staining was observed in these cell lines. In contrast, poorly invasive/nonmetastatic cell lines showed HP1Hsalpha localization to the nucleus and nuclear membrane. Transfection of MDA-MB-231 cells with a green fluorescent protein-HP1Hsalpha expression vector decreased their ability to invade a collagen IV/laminin/gelatin matrix compared with green fluorescent protein-transfected controls. Consistent with the cell culture studies, immunohistochemical analysis of HP1Hsalpha protein localization in distant metastatic tissues from breast cancer patients revealed a decrease in the staining intensity and percentage of cells expressing HP1Hsalpha in seven of nine distant metastatic lesions compared with normal mammary and primary tumors. These results demonstrate a role for HP1Hsalpha in breast cancer invasion and metastasis. Given the role of HP1 in transcriptional silencing in Drosophila, we propose a model in which HP1Hsalpha normally silences genes involved in breast cancer invasion and metastasis.

PubMed Disclaimer

Similar articles

• A requirement for dimerization of HP1Hsalpha in suppression of breast cancer invasion.
  Norwood LE, Moss TJ, Margaryan NV, Cook SL, Wright L, Seftor EA, Hendrix MJ, Kirschmann DA, Wallrath LL. Norwood LE, et al. J Biol Chem. 2006 Jul 7;281(27):18668-76. doi: 10.1074/jbc.M512454200. Epub 2006 Apr 28. J Biol Chem. 2006. PMID: 16648629
• Differentially expressed genes associated with the metastatic phenotype in breast cancer.
  Kirschmann DA, Seftor EA, Nieva DR, Mariano EA, Hendrix MJ. Kirschmann DA, et al. Breast Cancer Res Treat. 1999 May;55(2):127-36. doi: 10.1023/a:1006188129423. Breast Cancer Res Treat. 1999. PMID: 10481940
• Conserved properties of HP1(Hsalpha).
  Norwood LE, Grade SK, Cryderman DE, Hines KA, Furiasse N, Toro R, Li Y, Dhasarathy A, Kladde MP, Hendrix MJ, Kirschmann DA, Wallrath LL. Norwood LE, et al. Gene. 2004 Jul 7;336(1):37-46. doi: 10.1016/j.gene.2004.04.003. Gene. 2004. PMID: 15225874
• Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: role in epithelial cancer cell invasion, proliferation and nuclear regulation.
  Nicolson GL, Nawa A, Toh Y, Taniguchi S, Nishimori K, Moustafa A. Nicolson GL, et al. Clin Exp Metastasis. 2003;20(1):19-24. doi: 10.1023/a:1022534217769. Clin Exp Metastasis. 2003. PMID: 12650603 Review.
• Genetic analysis of breast cancer progression.
  Dairkee SH, Smith HS. Dairkee SH, et al. J Mammary Gland Biol Neoplasia. 1996 Apr;1(2):139-51. doi: 10.1007/BF02013638. J Mammary Gland Biol Neoplasia. 1996. PMID: 10887488 Review.

Cited by

• Exosomal miRNA-223-3p derived from tumor associated macrophages promotes pulmonary metastasis of breast cancer 4T1 cells.
  Wang Z, Zhang C, Guo J, Wang W, Si Q, Chen C, Luo Y, Duan Z. Wang Z, et al. Transl Oncol. 2023 Sep;35:101715. doi: 10.1016/j.tranon.2023.101715. Epub 2023 Jun 16. Transl Oncol. 2023. PMID: 37329828 Free PMC article.
• Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification.
  Sehgal P, Chaturvedi P. Sehgal P, et al. Cancers (Basel). 2023 Jan 11;15(2):466. doi: 10.3390/cancers15020466. Cancers (Basel). 2023. PMID: 36672415 Free PMC article. Review.
• CBX5 loss drives EGFR inhibitor resistance and results in therapeutically actionable vulnerabilities in lung cancer.
  Bugide S, Edwards YJK, Gupta R, Green MR, Wajapeyee N. Bugide S, et al. Proc Natl Acad Sci U S A. 2023 Jan 24;120(4):e2218118120. doi: 10.1073/pnas.2218118120. Epub 2023 Jan 18. Proc Natl Acad Sci U S A. 2023. PMID: 36652476 Free PMC article.
• Molecular interactions underlying the phase separation of HP1α: role of phosphorylation, ligand and nucleic acid binding.
  Her C, Phan TM, Jovic N, Kapoor U, Ackermann BE, Rizuan A, Kim YC, Mittal J, Debelouchina GT. Her C, et al. Nucleic Acids Res. 2022 Dec 9;50(22):12702-12722. doi: 10.1093/nar/gkac1194. Nucleic Acids Res. 2022. PMID: 36537242 Free PMC article.
• Heterochromatin Protein 1: A Multiplayer in Cancer Progression.
  Jeon YH, Kim GW, Kim SY, Yi SA, Yoo J, Kim JY, Lee SW, Kwon SH. Jeon YH, et al. Cancers (Basel). 2022 Feb 1;14(3):763. doi: 10.3390/cancers14030763. Cancers (Basel). 2022. PMID: 35159030 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal